Pragmatic Clinical Trials: On the Way from Niche to Necessity

Over the past decade, the number of U.S. trials labeled “pragmatic” has increased significantly. Once viewed as an approach with limited applicability, pragmatic trials are being looked at as an opportunity to expand access to trials, and an efficient way to answer regulatory questions. Introducing pragmatic elements such as simplified procedures and expanding eligibility criteria make it possible to collect data at the point of care that can answer questions important to regulators while also informing clinical care decisions at the bedside. 

Read the full article featuring Rob DiCicco from Healthcare Business Today here.